|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fernandes JV, DE Medeiros Fernandes TA, DE
Azevedo JC, Cobucci RN, DE Carvalho MG, Andrade VS and DE Araújo
JM: Link between chronic inflammation and human
papillomavirus-induced carcinogenesis (Review). Oncol Lett.
9:1015–1026. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perk J, Iavarone A and Benezra R: Id
family of helix-loop-helix proteins in cancer. Nat Rev Cancer.
5:603–614. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong YC, Wang X and Ling MT: Id-1
expression and cell survival. Apoptosis. 9:279–289. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han S, Gou C, Hong L, Liu J, ZheyiHa n,
Liu C, Wang J, Wu K, Ding J and Fan D: Expression and significances
of Id1 helix-loop-helix protein overexpression in gastric cancer.
Cancer Lett. 216:63–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cho Y, Cho EJ, Lee JH, Yu SJ, Kim YJ, Kim
CY and Yoon JH: Fucoidan-induced ID-1 suppression inhibits the in
vitro and in vivo invasion of hepatocellular carcinoma cells.
Biomed Pharmacother. 83:607–616. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jang KS, Han HX, Paik SS, Brown PH and
Kong G: Id-1 overexpression in invasive ductal carcinoma cells is
significantly associated with intratumoral microvessel density in
ER-negative/node-positive breast cancer. Cancer Lett. 244:203–210.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zielinski AJ, Fong S, Allison J, Kawahara
M, Coppe JP, Feiler H, Lee NM and Desprez PY: The helix-loop-helix
Id-1 inhibits PSA expression in prostate cancer cells. Int J
Cancer. 126:2490–2496. 2010.PubMed/NCBI
|
|
9
|
Li J, Jia H, Xie L, Wang X, He H, Lin Y
and Hu L: Correlation of inhibitor of differentiation 1 expression
to tumor progression, poor differentiation and aggressive behaviors
in cervical carcinoma. Gynecol Oncol. 114:89–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chandrika G, Natesh K, Ranade D, Chugh A
and Shastry P: Suppression of the invasive potential of
Glioblastoma cells by mTOR inhibitors involves modulation of NFKB
and PKC-α signaling. Sci Rep. 6:224552016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Jia H, Xie L, Wang X, Wang X, He H,
Lin Y and Hu L: Association of constitutive nuclear factor-kappaB
activation with aggressive aspects and poor prognosis in cervical
cancer. Int J Gynecol Cancer. 19:1421–1426. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng X, Wu Z, Yu L, Li J, Xu W, Chan HC,
Zhang Y and Hu L: Overexpression of cystic fibrosis transmembrane
conductance regulator (CFTR) is associated with human cervical
cancer malignancy, progression and prognosis. Gynecol Oncol.
125:470–476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hao L, Liao Q, Tang Q, Deng H and Chen L:
Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis
via PI3K/AKT signaling pathway. Biochem Biophys Res Commun.
470:643–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shuno Y, Tsuno NH, Okaji Y, Tsuchiya T,
Sakurai D, Nishikawa T, Yoshikawa N, Sasaki K, Hongo K, Tsurita G,
et al: Id1/Id3 knockdown inhibits metastatic potential of
pancreatic cancer. J Surg Res. 161:76–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Forootan SS, Wong YC, Dodson A, Wang X,
Lin K, Smith PH, Foster CS and Ke Y: Increased Id-1 expression is
significantly associated with poor survival of patients with
prostate cancer. Hum Pathol. 38:1321–1329. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun W, Guo MM, Han P, Lin JZ, Liang FY,
Tan GM, Li HB, Zeng M and Huang XM: Id-1 and the p65 subunit of
NF-KB promote migration of nasopharyngeal carcinoma cells and are
correlated with poor prognosis. Carcinogenesis. 33:810–817. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su Y, Gao L, Teng L, Wang Y, Cui J, Peng S
and Fu S: Id1 enhances human ovarian cancer endothelial progenitor
cell angiogenesis via PI3K/Akt and NF-KB/MMP-2 signaling pathways.
J Transl Med. 11:1322013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsai CH, Yang MH, Hung AC, Wu SC, Chiu WC,
Hou MF, Tyan YC, Wang YM and Yuan SF: Identification of Id1 as a
downstream effector for arsenic-promoted angiogenesis via PI3K/Akt,
NF-KB and NOS signaling. Toxicol Res (Camb). 5:151–159. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shin CH and Choi DS: Essential roles for
the Non-canonical IKB kinases in linking inflammation to cancer,
obesity, and diabetes. Cells. 8(pii): E1782019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Li Y, Wang B, Ma Y and Chen P: Id-1
promotes migration and invasion of non-small cell lung cancer cells
through activating NF-KB signaling pathway. J Biomed Sci.
24:952017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li B, Cheung PY, Wang X, Tsao SW, Ling MT,
Wong YC and Cheung AL: Id-1 activation of PI3K/Akt/NFkappaB
signaling pathway and its significance in promoting survival of
esophageal cancer cells. Carcinogenesis. 28:2313–2320. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Porquet N, Poirier A, Houle F, Pin AL,
Gout S, Tremblay PL, Paquet ER, Klinck R, Auger FA and Huot J:
Survival advantages conferred to colon cancer cells by
E-selectin-induced activation of the PI3K-NFKB survival axis
downstream of Death receptor-3. BMC Cancer. 11:2852011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma H, Wei Y, Leng Y, Li S, Gao L, Hu H,
Chen L, Wang F, Xiao H, Zhu C and Liang C: TGF-β1-induced
expression of Id-1 is associated with tumor progression in gastric
cancer. Med Oncol. 31:192014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roschger C and Cabrele C: The Id-protein
family in developmental and cancer-associated pathways. Cell Commun
Signal. 15:72017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma J, Shi M, Li G, Wang N, Wei J, Wang T,
Ma J and Wang Y: Regulation of Id1 expression by
epigallocatechin-3-gallate and its effect on the proliferation and
apoptosis of poorly differentiated AGS gastric cancer cells. Int J
Oncol. 43:1052–1058. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin J, Guan Z, Wang C, Feng L, Zheng Y,
Caicedo E, Bearth E, Peng JR, Gaffney P and Ondrey FG: Inhibitor of
differentiation 1 contributes to head and neck squamous cell
carcinoma survival via the NF-kappaB/survivin and phosphoinositide
3-kinase/Akt signaling pathways. Clin Cancer Res. 16:77–87. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li B, Tsao SW, Li YY, Wang X, Ling MT,
Wong YC, He QY and Cheung AL: Id-1 promotes tumorigenicity and
metastasis of human esophageal cancer cells through activation of
PI3K/AKT signaling pathway. Int J Cancer. 125:2576–2585. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang Y, Liou HC and Sun XH: Id1
potentiates NF-kappaB activation upon T cell receptor signaling. J
Biol Chem. 281:34989–34996. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thulasidasan AKT, Retnakumari AP, Shankar
M, Vijayakurup V, Anwar S, Thankachan S, Pillai KS, Pillai JJ,
Nandan CD, Alex VV, et al: Folic acid conjugation improves the
bioavailability and chemosensitizing efficacy of
curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel
chemotherapy. Oncotarget. 8:107374–107389. 2017. View Article : Google Scholar : PubMed/NCBI
|
